MARAVAI LIFESCIENCES HOLDINGS, INC. cotiza a 6.55 USD y tiene una capitalización bursátil de $976M. En los últimos 12 meses ha facturado $209M con un margen de flujo de caja libre del -38.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segme…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.02 | $0.01 | $-0.04 |
| Estimado | $-0.06 | $-0.04 | $-0.05 | $-0.07 |
| Sorpresa | — | +50.0% | +120.0% | +42.9% |
| Métrica | MRVI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 18.3% | 57.0% | -38.7% |
| Operating Margin | -115.9% | -38.6% | -77.3% |
| Net Margin | -70.4% | -33.6% | -36.8% |
| FCF Margin | -38.1% | -13.9% | -24.2% |
| ROE | -61.6% | -40.4% | -21.2% |
| ROA | -17.0% | -32.0% | +15.0% |
| Current Ratio | 6.60 | 2.84 | +3.76 |
| Debt / Equity | 1.37 | 0.28 | +1.09 |